AVBP

ArriVent BioPharma, Inc. - Common Stock (AVBP)

About ArriVent BioPharma, Inc. - Common Stock (AVBP)

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Details

Daily high

$22.32

Daily low

$20.94

Price at open

$21.66

52 Week High

$36.37

52 Week Low

$15.47

Market cap

783.1M

Dividend yield

0.00%

Volume

257,442

Avg. volume

517,440

P/E ratio

-5.67

ArriVent BioPharma, Inc. - Common Stock News